List of True North Therapeutics patents

List of True North Therapeutics patents

List of Samson Rope Technologies patents

List of Yubico patents

List of Watts Water Technologies patents

List of founders from Alberta

List of companies in Kennedy Lewis Investment Management Llc's investment portfolio

Patents where

Current Assignee

Name

is

True North Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9512233 Anti-complement C1s antibodies and methods of inhibiting complement C1s activity	Patent 9512233 was granted and assigned to True North Therapeutics on December, 2016 by the United States Patent and Trademark Office.	True North Therapeutics	True North Therapeutics		United States Patent and Trademark Office	9512233	December 6, 2016
	‌ US Patent 9562106 Anti-complement C1s antibodies and methods of inhibiting complement C1s activity	Patent 9562106 was granted and assigned to True North Therapeutics on February, 2017 by the United States Patent and Trademark Office.	True North Therapeutics	True North Therapeutics		United States Patent and Trademark Office	9562106	February 7, 2017
	‌ US Patent 9074003 Methods of inhibiting activation of complement component C4 with anti-C1s antibodies	Patent 9074003 was granted and assigned to True North Therapeutics on July, 2015 by the United States Patent and Trademark Office.	True North Therapeutics	True North Therapeutics		United States Patent and Trademark Office	9074003	July 7, 2015
	‌ US Patent 8945562 Anti-complement C1s antibodies	Patent 8945562 was granted and assigned to True North Therapeutics on February, 2015 by the United States Patent and Trademark Office.	True North Therapeutics	True North Therapeutics		United States Patent and Trademark Office	8945562	February 3, 2015
	‌ US Patent 9562092 Methods of inhibiting complement C4 activation with anti-complement C1s antibodies	Patent 9562092 was granted and assigned to True North Therapeutics on February, 2017 by the United States Patent and Trademark Office.	True North Therapeutics	True North Therapeutics		United States Patent and Trademark Office	9562092	February 7, 2017
	‌ US Patent 9074004 Methods of inhibiting activation of complement component C4 with anti-C1s antibodies	Patent 9074004 was granted and assigned to True North Therapeutics on July, 2015 by the United States Patent and Trademark Office.	True North Therapeutics	True North Therapeutics		United States Patent and Trademark Office	9074004	July 7, 2015
	‌ US Patent 9206259 Methods of inhibiting complement C4 activation with anti-complement C1S antibodies	Patent 9206259 was granted and assigned to True North Therapeutics on December, 2015 by the United States Patent and Trademark Office.	True North Therapeutics	True North Therapeutics		United States Patent and Trademark Office	9206259	December 8, 2015
	‌ US Patent 8877197 Anti-complement C1s	Patent 8877197 was granted and assigned to True North Therapeutics on November, 2014 by the United States Patent and Trademark Office.	True North Therapeutics	True North Therapeutics		United States Patent and Trademark Office	8877197	November 4, 2014

8 results

0 selected

8 results

0 selected